|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_ocn797918286 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
121126s2009 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d IDEBK
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d ZCU
|d OCLCQ
|d MERUC
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780470717684
|
| 020 |
|
|
|a 0470717688
|
| 029 |
1 |
|
|a DEBBG
|b BV044154878
|
| 029 |
1 |
|
|a DEBSZ
|b 430999356
|
| 029 |
1 |
|
|a DEBSZ
|b 449244997
|
| 035 |
|
|
|a (OCoLC)797918286
|
| 050 |
|
4 |
|a QR187.3 .S95
|
| 082 |
0 |
4 |
|a 574.2/ 9
|a 574.2/9
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Symposium, CIBA Foundation.
|
| 245 |
1 |
0 |
|a Immunopotentiation.
|
| 260 |
|
|
|a Hoboken :
|b John Wiley & Sons,
|c 2009.
|
| 300 |
|
|
|a 1 online resource (368 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Novartis Foundation Symposia
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Immunopotentiation; Contents; Introduction; The cellular targets for the action of adjuvants : T-adjuvants and B-adjuvants; Discussion; The relation of lymphocyte trapping to the mode of action of adjuvants; Discussion; Immunopotentiation by mycobacteria in complete Freund-type adjuvant as the failure of normal immunological homeostasis; Discussion; Effects of adjuvants on different cell types and their interactions in immune responses; Discussion; Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvurn: interactions of activated macrophages with T and B lymphocytes.
|
| 505 |
8 |
|
|a DiscussionChemotaxis of macrophages : the role of a macrophage-specific cytotaxin from anaerobic corynebacteria and its relation to immunopotentiation in vivo; Discussion; The allogeneic effect on the immune system and its potential applications to tumour immunity; Discussion; Mitogens as probes for immunocyte activ- ation : specific and non-specific paralysis of B cell mitogenesis; Discussion; General Discussion I The T cell-deprived mouse; The use of viruses as immunological potentiators; Discussion.
|
| 505 |
8 |
|
|a Corynebacterium parvum, a potent immunostimu-lant in experimental infections and in malignanciesDiscussion; Orchidectomy as a method of immunopotentiation in mice; Discussion; The nature of immunopotentiation by the anti-tumour polysaccharide lentinan and the significance of biogenic amines in its action; Discussion; The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice; Discussion; Attempt at using systemic immunity adjuvants in experimental and human cancer therapy; Discussion.
|
| 505 |
8 |
|
|a General Discussion II Restoration of immune capability in cancer patientsSites of action of adjuvants; Conclusion; Index of contributors; Subject index.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Immunological adjuvants
|v Congresses.
|
| 650 |
|
0 |
|a Tumors
|x Immunological aspects
|v Congresses.
|
| 650 |
|
6 |
|a Adjuvants immunologiques
|v Congrès.
|
| 650 |
|
6 |
|a Tumeurs
|x Immunologie
|v Congrès.
|
| 650 |
|
7 |
|a Immunological adjuvants
|2 fast
|
| 650 |
|
7 |
|a Tumors
|x Immunological aspects
|2 fast
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
| 776 |
0 |
8 |
|i Print version:
|a Symposium, CIBA Foundation.
|t Immunopotentiation.
|d Hoboken : John Wiley & Sons, ©2009
|z 9780470663110
|
| 830 |
|
0 |
|a Novartis Foundation Symposia.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=703843
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL703843
|
| 938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 369375
|
| 994 |
|
|
|a 92
|b IZTAP
|
